Satellos Bioscience MSLE
NASDAQ MSLE
$8.60 -0.21 (-2.38%)
At close: Sep 29, 2026 · 4:00 PM EDT

Satellos Bioscience (MSLE) Receivables (2024 - 2026)

Updated

Satellos Bioscience (MSLE) recorded Receivables of $370,000 in the quarter ended Jun 30, 2026, unchanged from the prior quarter.

Analysis

Satellos Bioscience (MSLE) Receivables (2024 - 2026) Analysis & Trends

Starting with the quarter ended Dec 31, 2024, Satellos Bioscience's Receivables history includes 4 quarters.

  • Across earlier years, Receivables came in at $448,122 in the year ended Dec 31, 2024.
  • Quarterly Receivables has ranged from $370,000 in the quarter ended Dec 31, 2025 to $448,122 in the quarter ended Dec 31, 2024 over the past five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 19.05 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 13.82 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.68 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.13 Bn
10 Satellos Bioscience 136.19 Mn 136.19 Mn - 370,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 370,000.00
Mar 31, 2026 370,000.00
Dec 31, 2025 370,000.00
Dec 31, 2024 448,121.56
API Access

Satellos Bioscience Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=MSLE&period=max&api_key=YOUR_API_KEY